论文信息 - Phase III study of gemcitabine/oxaliplatin (GEMOX) with or without erlotinib in unresectable, metastatic biliary tract carcinoma. - 字舞流文

Phase III study of gemcitabine/oxaliplatin (GEMOX) with or without erlotinib in unresectable, metastatic biliary tract carcinoma.

H. Jang | D. Shin | H. Jeung | W. Kang | J. Kim | H. Lim | S. Park | J. Park | Y. Park | J. Jang | J. Lee | J. Kang | H. Lee | J. Sun | M. Lee | H. Choi | H. Chang